|
|
||||||||







,
*
Department of Pathobiology, University of Washington, Seattle, WA 98195; and
Infectious Disease Research Institute and
CORIXA Corporation, Seattle, WA 98104
Polypeptide Ags present in the culture filtrate of
Mycobacterium tuberculosis were purified and evaluated
for their ability to stimulate PBMC from purified protein derivative
(PPD)-positive healthy donors. One such Ag, which elicited strong
proliferation and IFN-
production, was further characterized. The
N-terminal amino acid sequence of this polypeptide was determined and
used to design oligonucleotides for screening a recombinant M.
tuberculosis genomic DNA library. The gene (Mtb
8.4) corresponding to the identified polypeptide was cloned,
sequenced, and expressed in Escherichia coli. The
predicted m.w. of the recombinant protein without its signal peptide
was 8.4 kDa. By Southern analysis, the DNA encoding this mycobacterial
protein was found in the M. tuberculosis substrains
H37Rv, H37Ra, Erdman, and "C" strain, as well as in certain other
mycobacterial species, including Mycobacterium avium and
Mycobacterium bovis BCG (bacillus Calmette-Guérin,
Pasteur). The Mtb 8.4 gene appears to be absent from the
environmental mycobacterial species examined thus far, including
Mycobacterium smegmatis, Mycobacterium
gordonae, Mycobacterium chelonae,
Mycobacterium fortuitum, and Mycobacterium
scrofulaceum. Recombinant Mtb 8.4 Ag induced significant
proliferation as well as production of IFN-
, IL-10, and TNF-
, but
not IL-5, from human PBMC isolated from PPD-positive healthy donors.
Mtb 8.4 did not stimulate PBMC from PPD-negative donors. Furthermore,
immunogenicity studies in mice indicate that Mtb 8.4 elicits a Th1
cytokine profile, which is considered important for protective immunity
to tuberculosis. Collectively, these results demonstrate that Mtb 8.4
is an immunodominant T cell Ag of M.
tuberculosis.
This article has been cited by other articles:
![]() |
B. Sidders, C. Pirson, P. J. Hogarth, R. G. Hewinson, N. G. Stoker, H. M. Vordermeier, and K. Ewer Screening of Highly Expressed Mycobacterial Genes Identifies Rv3615c as a Useful Differential Diagnostic Antigen for the Mycobacterium tuberculosis Complex Infect. Immun., September 1, 2008; 76(9): 3932 - 3939. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Coler, Y. Goto, L. Bogatzki, V. Raman, and S. G. Reed Leish-111f, a Recombinant Polyprotein Vaccine That Protects against Visceral Leishmaniasis by Elicitation of CD4+ T Cells Infect. Immun., September 1, 2007; 75(9): 4648 - 4654. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Mustafa, Y. A. Skeiky, R. Al-Attiyah, M. R. Alderson, R. G. Hewinson, and H. M. Vordermeier Immunogenicity of Mycobacterium tuberculosis Antigens in Mycobacterium bovis BCG-Vaccinated and M. bovis-Infected Cattle. Infect. Immun., August 1, 2006; 74(8): 4566 - 4572. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Lewinsohn, J. E. Grotzke, A. S. Heinzel, L. Zhu, P. J. Ovendale, M. Johnson, and M. R. Alderson Secreted Proteins from Mycobacterium tuberculosis Gain Access to the Cytosolic MHC Class-I Antigen-Processing Pathway J. Immunol., July 1, 2006; 177(1): 437 - 442. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mukherjee, S. S. Kashino, Y. Zhang, N. Daifalla, V. Rodrigues Jr, S. G. Reed, and A. Campos-Neto Cloning of the Gene Encoding a Protective Mycobacterium tuberculosis Secreted Protein Detected In Vivo during the Initial Phases of the Infectious Process J. Immunol., October 15, 2005; 175(8): 5298 - 5305. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Shin, C.-F. Chang, C.-D. Chang, S. P. McDonough, B. Thompson, H. S. Yoo, and Y.-F. Chang In Vitro Cellular Immune Responses to Recombinant Antigens of Mycobacterium avium subsp. paratuberculosis Infect. Immun., August 1, 2005; 73(8): 5074 - 5085. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. A. W. Skeiky, M. R. Alderson, P. J. Ovendale, J. A. Guderian, L. Brandt, D. C. Dillon, A. Campos-Neto, Y. Lobet, W. Dalemans, I. M. Orme, et al. Differential Immune Responses and Protective Efficacy Induced by Components of a Tuberculosis Polyprotein Vaccine, Mtb72F, Delivered as Naked DNA or Recombinant Protein J. Immunol., June 15, 2004; 172(12): 7618 - 7628. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Vekemans, M. O. C. Ota, J. Sillah, K. Fielding, M. R. Alderson, Y. A. W. Skeiky, W. Dalemans, K. P. W. J. McAdam, C. Lienhardt, and A. Marchant Immune Responses to Mycobacterial Antigens in the Gambian Population: Implications for Vaccines and Immunodiagnostic Test Design Infect. Immun., January 1, 2004; 72(1): 381 - 388. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Huygen On the Use of DNA Vaccines for the Prophylaxis of Mycobacterial Diseases Infect. Immun., April 1, 2003; 71(4): 1613 - 1621. [Full Text] |
||||
![]() |
F. H. Day, Y. Zhang, P. Clair, K. H. Grabstein, M. Mazel, A. R. Rees, M. Kaczorek, and J. Temsamani Induction of Antigen-Specific CTL Responses Using Antigens Conjugated to Short Peptide Vectors J. Immunol., February 1, 2003; 170(3): 1498 - 1503. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Coler, Y. A. W. Skeiky, K. Bernards, K. Greeson, D. Carter, C. D. Cornellison, F. Modabber, A. Campos-Neto, and S. G. Reed Immunization with a Polyprotein Vaccine Consisting of the T-Cell Antigens Thiol-Specific Antioxidant, Leishmania major Stress-Inducible Protein 1, and Leishmania Elongation Initiation Factor Protects against Leishmaniasis Infect. Immun., August 1, 2002; 70(8): 4215 - 4225. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Delogu, A. Li, C. Repique, F. Collins, and S. L. Morris DNA Vaccine Combinations Expressing Either Tissue Plasminogen Activator Signal Sequence Fusion Proteins or Ubiquitin-Conjugated Antigens Induce Sustained Protective Immunity in a Mouse Model of Pulmonary Tuberculosis Infect. Immun., January 1, 2002; 70(1): 292 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Coler, A. Campos-Neto, P. Ovendale, F. H. Day, S. P. Fling, L. Zhu, N. Serbina, J. L. Flynn, S. G. Reed, and M. R. Alderson Vaccination with the T Cell Antigen Mtb 8.4 Protects Against Challenge with Mycobacterium tuberculosis J. Immunol., May 15, 2001; 166(10): 6227 - 6235. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Katial, J. Hershey, T. Purohit-Seth, J. T. Belisle, P. J. Brennan, J. S. Spencer, and R. J. M. Engler Cell-Mediated Immune Response to Tuberculosis Antigens: Comparison of Skin Testing and Measurement of In Vitro Gamma Interferon Production in Whole-Blood Culture Clin. Vaccine Immunol., March 1, 2001; 8(2): 339 - 345. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Lewinsohn, L. Zhu, V. J. Madison, D. C. Dillon, S. P. Fling, S. G. Reed, K. H. Grabstein, and M. R. Alderson Classically Restricted Human CD8+ T Lymphocytes Derived from Mycobacterium tuberculosis-Infected Cells: Definition of Antigenic Specificity J. Immunol., January 1, 2001; 166(1): 439 - 446. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. A. W. Skeiky, P. J. Ovendale, S. Jen, M. R. Alderson, D. C. Dillon, S. Smith, C. B. Wilson, I. M. Orme, S. G. Reed, and A. Campos-Neto T Cell Expression Cloning of a Mycobacterium tuberculosis Gene Encoding a Protective Antigen Associated with the Early Control of Infection J. Immunol., December 15, 2000; 165(12): 7140 - 7149. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G. Wiker, M. A. Wilson, and G. K. Schoolnik Extracytoplasmic proteins of Mycobacterium tuberculosis - mature secreted proteins often start with aspartic acid and proline Microbiology, July 1, 2000; 146(7): 1525 - 1533. [Abstract] [Full Text] |
||||
![]() |
J. M. Musser, A. Amin, and S. Ramaswamy Negligible Genetic Diversity of Mycobacterium tuberculosis Host Immune System Protein Targets: Evidence of Limited Selective Pressure Genetics, May 1, 2000; 155(1): 7 - 16. [Abstract] [Full Text] |
||||
![]() |
M. Gomez, S. Johnson, and M. L. Gennaro Identification of Secreted Proteins of Mycobacterium tuberculosis by a Bioinformatic Approach Infect. Immun., April 1, 2000; 68(4): 2323 - 2327. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Alderson, T. Bement, C. H. Day, L. Zhu, D. Molesh, Y. A. W. Skeiky, R. Coler, D. M. Lewinsohn, S. G. Reed, and D. C. Dillon Expression Cloning of an Immunodominant Family of Mycobacterium tuberculosis Antigens Using Human CD4+ T Cells J. Exp. Med., February 7, 2000; 191(3): 551 - 560. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. V. Skjot, T. Oettinger, I. Rosenkrands, P. Ravn, I. Brock, S. Jacobsen, and P. Andersen Comparative Evaluation of Low-Molecular-Mass Proteins from Mycobacterium tuberculosis Identifies Members of the ESAT-6 Family as Immunodominant T-Cell Antigens Infect. Immun., January 1, 2000; 68(1): 214 - 220. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. A. W. Skeiky, M. J. Lodes, J. A. Guderian, R. Mohamath, T. Bement, M. R. Alderson, and S. G. Reed Cloning, Expression, and Immunological Evaluation of Two Putative Secreted Serine Protease Antigens of Mycobacterium tuberculosis Infect. Immun., August 1, 1999; 67(8): 3998 - 4007. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |